Peter B. Bach, MD
@peterbachmd
Followers
13K
Following
12K
Media
385
Statuses
12K
Chief Med Officer @DELFIdiagnostic. Pulmonary & ICU doc. Tweets about health policy and grammar. Viewpoints my own.
New York, NY
Joined April 2011
Excellent piece from @zackcooperYale on why US health care costs are so high — prices, admin costs from tying coverage to your work, expectation to adopt the newest tech regardless of value — and the choices available to address them.
nytimes.com
The high cost of health care in America is suppressing wages, driving job losses and fueling inequality.
4
82
243
Hype or hope? Multi-cancer blood tests promise to spot dozens of cancers early- but does the evidence stack up? Today on @BBCFileOn4 I dig into one of medicine’s toughest topics: screening, & what this new tech might really mean for patients & the NHS https://t.co/0ZPgkhNkYm
bbc.co.uk
Could multi-cancer detection tests help improve earlier diagnosis for NHS patients?
2
10
16
Don't miss Nicholas Thompson and Daniel J. Levitin in conversation discussing The Running Ground. 📍 Kepler's Books, Menlo Park, CA 📅 Saturday, November 22 at 4pm 🎟️ Tickets available now: https://t.co/LMxy8CtpdH
0
1
1
Christmas Is Here Stuff Those Stocking With ICESPIKE!!! The Best Stocking Stuffer Ever!!!
0
3
9
And that is assuming the interest rate is the same for 50 and 30 years. But very likely to be considerably higher given the longer risk horizon.
Let's say you take out a $400,000 mortgage loan at 6.25% - and choose a 50-year mortgage instead of 30 yrs. In return for saving $283 monthly, you will pay an extra $421,302 in interest over the life of loan. Or if you sell at 15 yrs, will have paid off just $29,000 in equity.
0
0
2
Sarepta Therapeutics has refused the FDA’s request that it pull gene therapy from the market following patient deaths
statnews.com
The FDA will request Sarepta Therapeutics stop all shipments of Elevidys, its gene therapy for Duchenne muscular dystrophy, following two deaths tied to the product.
3
6
13
Good summary of key issues. Cancer drugs cost more than ever, but some blockbuster treatments have never proven they keep patients alive longer https://t.co/6SZ871gPaz via @bbgvisualdata
bloomberg.com
Pharmaceutical companies are making billions on treatments that can sometimes overpromise and underdeliver for terminal cases.
0
4
5
Even the NYT seems to have forgotten that debt is a function of both revenue and spending. No mention here of increasing taxes as part of the solution as if it isn't a lever. https://t.co/Ffn7gTas3Q
1
0
4
Even the most self-sufficient kids need a squad to take on the ARC. Token Black knows the value of teamwork (and a deep wallet). Rally your friends and dive into ARC Raiders to fight the good fight. If you’re lucky, maybe Token will spot you some high-end upgrades.
0
43
1K
Thinking about my dad, Fritz Bach, today. Stateless in 1948, disembarked the Marine Tiger at New York harbor, welcomed to this country of unlimited potential. Every time we were in Times Square he would tell me about the night he saw it for the first time with his brother Bert.
0
1
5
Firearm Laws & Pediatric Mortality in US One of our more imp papers; great team effort led by @jeremyfaust 'permissive firearm laws contributed to thousands of excess firearm deaths among children in states w/permissive policies' @YaleMed @harvardmed
https://t.co/PFTLwlTWQa
jamanetwork.com
This study attempts to measure excess mortality due to firearms among US children aged 0 to 17 years after the McDonald v Chicago US Supreme Court decision (2010).
1
9
17
Somehow this headline feels like a Harvard is trolling in a very Harvard way
npr.org
A pair of U.K. scholars discovered the mislabeled document in Harvard Law School's digital archives. The university bought it for just $27.50 in 1946. It turned out to be an authentic copy dating to...
0
0
2
If we are talking MFN for drug pricing, ditch three false framings first. - Not 'price controls', changes prices offered and voluntarily accepted - Int'l price diff reflect price discrimination based on WTP, not US subsidy - Int'l price diff are real and large, net of rebates
2
0
10
“Moral Ambition” by @rcbregman arrives today in the US! That man has the best handwriting I’ve ever seen. 😀 Congrats Rutger the world definitely needs more moral ambition. https://t.co/KZRcQDxtHO
11
18
136
Great piece from @dr_kkjetelina and the importance of listening to the other side at this difficult moment in public health. Went in with a plan to have her listen to talk ratio at 3:1. This is how to improve health with information.
1
6
20
You can now talk to Google Sheets. No typing. No formulas. Just conversation. Edison AI can create sheets, add data, find records, and update anything — all from a simple prompt. This is how software should work in 2026. @edisonai_io
0
3
9
A peek into @GardinerHarris book "No More Tears" in @statnews. The piece focuses on JnJ's role in pushing EPO after data were definitive that it was harmful. The book marches out a laundry list of equally concerning actions by the company. It's harrowing.
statnews.com
Erythropoietin, aka EPO, is best known for its role in the Lance Armstrong cheating scandal. But EPO is also the star of another, darker tale.
0
0
1
With the unfortunate news about @23andMe today, here is my profile of @annewoj23 in 2015 for @TandCmag right after the company's first encounter with the FDA.
townandcountrymag.com
Anne Wojcicki is on a mission to gather your genetic secrets so her company, 23AndMe, can help change your approach to health and well-being.
0
0
2
With the unfortunate news about @23andMe today, here is the profile I wrote of @annewoj23 in 2015 right after their encounter with the FDA.
townandcountrymag.com
Anne Wojcicki is on a mission to gather your genetic secrets so her company, 23AndMe, can help change your approach to health and well-being.
0
0
0
The latest Microsoft Research Forum episode is now available on-demand. Explore purposeful research and its real-world impact.
7
10
70
